Recommendations for evaluating the safety of medicinal products containing nanoparticles
Recommendations for preclinical safety assessment of medicinal products containing nanoparticles are presented. The recommendations provide conditions for research acute and chronic toxicity of nanotherapeutics, methods for their quantitative and qualitative assessments.
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2018-02-01
|
Series: | Безопасность и риск фармакотерапии |
Subjects: | |
Online Access: | https://www.risksafety.ru/jour/article/view/25 |
_version_ | 1797224628778696704 |
---|---|
author | R. N. Alyautdin B. K. Romanov |
author_facet | R. N. Alyautdin B. K. Romanov |
author_sort | R. N. Alyautdin |
collection | DOAJ |
description | Recommendations for preclinical safety assessment of medicinal products containing nanoparticles are presented. The recommendations provide conditions for research acute and chronic toxicity of nanotherapeutics, methods for their quantitative and qualitative assessments. |
first_indexed | 2024-03-08T22:27:43Z |
format | Article |
id | doaj.art-c23eee9836a947178fa9b752d9df57c6 |
institution | Directory Open Access Journal |
issn | 2312-7821 2619-1164 |
language | Russian |
last_indexed | 2024-04-24T13:56:09Z |
publishDate | 2018-02-01 |
publisher | Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» |
record_format | Article |
series | Безопасность и риск фармакотерапии |
spelling | doaj.art-c23eee9836a947178fa9b752d9df57c62024-04-03T17:56:36ZrusMinistry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»Безопасность и риск фармакотерапии2312-78212619-11642018-02-0104102225Recommendations for evaluating the safety of medicinal products containing nanoparticlesR. N. Alyautdin0B. K. Romanov1Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», Ministry of Health of the Russian FederationFederal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», Ministry of Health of the Russian FederationRecommendations for preclinical safety assessment of medicinal products containing nanoparticles are presented. The recommendations provide conditions for research acute and chronic toxicity of nanotherapeutics, methods for their quantitative and qualitative assessments.https://www.risksafety.ru/jour/article/view/25нанотехнологиитоксичностьлекарственное средствоnanotechnologytoxicitydrug |
spellingShingle | R. N. Alyautdin B. K. Romanov Recommendations for evaluating the safety of medicinal products containing nanoparticles Безопасность и риск фармакотерапии нанотехнологии токсичность лекарственное средство nanotechnology toxicity drug |
title | Recommendations for evaluating the safety of medicinal products containing nanoparticles |
title_full | Recommendations for evaluating the safety of medicinal products containing nanoparticles |
title_fullStr | Recommendations for evaluating the safety of medicinal products containing nanoparticles |
title_full_unstemmed | Recommendations for evaluating the safety of medicinal products containing nanoparticles |
title_short | Recommendations for evaluating the safety of medicinal products containing nanoparticles |
title_sort | recommendations for evaluating the safety of medicinal products containing nanoparticles |
topic | нанотехнологии токсичность лекарственное средство nanotechnology toxicity drug |
url | https://www.risksafety.ru/jour/article/view/25 |
work_keys_str_mv | AT rnalyautdin recommendationsforevaluatingthesafetyofmedicinalproductscontainingnanoparticles AT bkromanov recommendationsforevaluatingthesafetyofmedicinalproductscontainingnanoparticles |